Willow Biosciences is the result of a three-way merger between University of Calgary spinout Epimeron, BioCan Technologies and CSE-listed Makena Resources.
Epimeron, a Canada-based biotechnology spinout of University of Calgary, and cannabis producer BioCan Technologies have completed their reverse merger with exploration company Makena Resources to form Willow Biosciences.
The new business listed on the Canadian Securities Exchange on Monday after completing a private placement of $29m, with cannabis-focused private equity firm Tuatara Capital supplying $21m. Makena was previously listed on the same stock exchange.
Willow Biosciences will focus on cannabinoid biosynthetic production through all stages of development, from…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
